Constance Peyrottes

Title: Constance Peyrottes: Innovator in Kidney Disease Treatment

Introduction

Constance Peyrottes is a notable inventor based in Le Castera, France. She has made significant contributions to the field of medical innovation, particularly in the treatment of kidney diseases. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Her latest patents focus on the use of CER-001 therapy for treating kidney disease. This therapy involves a negatively charged lipoprotein complex that comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG). The patent details methods for treating subjects with kidney diseases, particularly those associated with a lecithin cholesterol acyl transferase (LCAT) deficiency. This innovative approach highlights the potential of CER-001 in addressing complex kidney conditions.

Career Highlights

Constance Peyrottes is currently associated with Abionyx Pharma, a company dedicated to developing innovative therapies. Her work at Abionyx Pharma has been instrumental in advancing research and development in the field of kidney disease treatment.

Collaborations

Some of her notable coworkers include Jean-Louis Henri Dasseux and Laura Calabresi. Their collaboration has contributed to the success of various projects within the company.

Conclusion

Constance Peyrottes stands out as a pioneering inventor in the medical field, particularly in the treatment of kidney diseases. Her innovative work and collaborations are making a significant impact on healthcare solutions.